1.
Chen Z-S, Yang D-H. Selection of optimal therapeutic modality for early-stage extranodal natural killer/T-cell lymphoma patients under the guidance of single-nucleotide polymorphism signature. Bosn J of Basic Med Sci [Internet]. 2021Aug.24 [cited 2021Oct.21];. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/6419